C09998628 / invoice 10000
Species:CANINE
Breed:Beaglier
Age (years):10
Diagnosis or signs:Abdominal Ultrasound
IV fluids
Medications for hepatopathy
Consult notes
Abdo U/S + IVFT HISTORY Sore abdomen noted on Wednesday 4/4/26. Ate well last night, but has a slightly reduced appetite. No V/D. Started on Gabapentin 300mg BID, started on Hepatoadvanced large 1 tablet daily. No previous anaesthetic reactions. Vaccinated. Has pet insurance. CLINICAL EXAM MM: Pink, moist CRT: <2 sec LN: WNL HR: 92, no murmurs RR: 12 Abdo: Tensed, more comfortable than yesterday Temp: IVC placed. Medications; Buprenorphine (0.3mg/ml) @ 0.01mg/kg = 0.91ml IV @ 9am IV sedation: Medetomidine (1mg/ml) @ 0.005mg/kg = 0.15ml IV Alfax titrated to effect - 1ml given to facilitate smooth abdo US. IVFT with hartmann's @ 89ml/kr. Abdo US: Performed by Dr. Jarrad @ PVU Impressions. 1. Assessing imaging findings in conjunction with the increased hepatic biochemistry an underlying inflammatory/infectious hepatopathy must be considered most likely. Consider hepatic supportive medical management and if there is clinical concern monitoring coagulation parameters and fine needle hepatic biopsy. 2. Mild gastric stasis. The gastric contents have the appearance of ingesta. Mild duodenal ileus was also noted. 3. Scaring and fibrosis of the pancreas is consistent with recently or previously resolved episodes of pancreatitis. If warranted consider dietary modification. Assessment: Anti-emetics: Metoclopramide (5mg/ml) @ 0.5mg/kg = 2.7ml SC @ 11:30am Maropitant (10mg/ml) @ 1mg/kg = 2.7ml IV @ 4pm prior to discharge Medications: Hepatoadvanced Large Chew - Liver Support/Supplement Chew - Previously dispensed Give 1 tablet by mouth ONCE DAILY. Give on an EMPTY stomach 1 hour BEFORE food. Next dose due Friday evening, 1 hour BEFORE a meal on an empty stomach (6/3/26). Amoxy-clav 500mg x 20 Tablets - Antibiotic Tablet Give 1 tablet by mouth TWICE DAILY until finished. Can be given with food. Next dose due Friday evening (6/3/26). Metoclopramide 10mg x 10 Tablets - Anti-nausea & Pro-kinetic Give 1 tablet by mouth TWICE DAILY until finished. Reduce nausea and increase appetite. Next dose due Friday evening (6/3/26). Ondansetron 8mg Wafers x 12 Tablets - Anti-nausea Tablet Give 2 tablets by mouth TWICE DAILY, to reduce nausea. Next dose due Friday evening (6/3/26). Gabapentin 300mg - Pain Relief Capsule - Previously dispensed Give 1 capsule by mouth TWICE to THREE TIMES daily, as required for pain relief. May cause mild sedation. Can be given with or without food, opened or whole or in a syringe with a small amount of water. Next dose due Friday evening (6/3/25). Plan: Charlie's liver is inflammed, and causing him to feel unwell, nauseous and flat. Supportive care is required to reduce this inflammation, including pain relief, antibiotics and anti-emetics/anti-nausea agents. Encourage Charlie to eat and drink is important. Please feed Charlie a bland diet (no raw meat) for the next 2 - 4 weeks. Please monitor for any vomiting, inappetence, lethargy, bruising, collapse, or other signs of concern. A blood sample has been sent to the lab to check Charlie's coagulation parameters. These results will be available early next week and we will contact you with the results. A follow up recheck is recommended in 1 weeks time (or earlier if concerned). Repeat blood test to check liver parameters is recommended in 4 weeks time - at the end of the Hepatoadvanced liver supplement box.
Animal clinical history (3 most recent)
2026-03-06T00:00:00Z 11:58:00
Abdo U/S + IVFT HISTORY Sore abdomen noted on Wednesday 4/4/26. Ate well last night, but has a slightly reduced appetite. No V/D. Started on Gabapentin 300mg BID, started on Hepatoadvanced large 1 tablet daily. No previous anaesthetic reactions. Vaccinated. Has pet insurance. CLINICAL EXAM MM: Pink, moist CRT: <2 sec LN: WNL HR: 92, no murmurs RR: 12 Abdo: Tensed, more comfortable than yesterday Temp: IVC placed. Medications; Buprenorphine (0.3mg/ml) @ 0.01mg/kg = 0.91ml IV @ 9am IV sedation: Medetomidine (1mg/ml) @ 0.005mg/kg = 0.15ml IV Alfax titrated to effect - 1ml given to facilitate smooth abdo US. IVFT with hartmann's @ 89ml/kr. Abdo US: Performed by Dr. Jarrad @ PVU Impressions. 1. Assessing imaging findings in conjunction with the increased hepatic biochemistry an underlying inflammatory/infectious hepatopathy must be considered most likely. Consider hepatic supportive medical management and if there is clinical concern monitoring coagulation parameters and fine needle hepatic biopsy. 2. Mild gastric stasis. The gastric contents have the appearance of ingesta. Mild duodenal ileus was also noted. 3. Scaring and fibrosis of the pancreas is consistent with recently or previously resolved episodes of pancreatitis. If warranted consider dietary modification. Assessment: Anti-emetics: Metoclopramide (5mg/ml) @ 0.5mg/kg = 2.7ml SC @ 11:30am Maropitant (10mg/ml) @ 1mg/kg = 2.7ml IV @ 4pm prior to discharge Medications: Hepatoadvanced Large Chew - Liver Support/Supplement Chew - Previously dispensed Give 1 tablet by mouth ONCE DAILY. Give on an EMPTY stomach 1 hour BEFORE food. Next dose due Friday evening, 1 hour BEFORE a meal on an empty stomach (6/3/26). Amoxy-clav 500mg x 20 Tablets - Antibiotic Tablet Give 1 tablet by mouth TWICE DAILY until finished. Can be given with food. Next dose due Friday evening (6/3/26). Metoclopramide 10mg x 10 Tablets - Anti-nausea & Pro-kinetic Give 1 tablet by mouth TWICE DAILY until finished. Reduce nausea and increase appetite. Next dose due Friday evening (6/3/26). Ondansetron 8mg Wafers x 12 Tablets - Anti-nausea Tablet Give 2 tablets by mouth TWICE DAILY, to reduce nausea. Next dose due Friday evening (6/3/26). Gabapentin 300mg - Pain Relief Capsule - Previously dispensed Give 1 capsule by mouth TWICE to THREE TIMES daily, as required for pain relief. May cause mild sedation. Can be given with or without food, opened or whole or in a syringe with a small amount of water. Next dose due Friday evening (6/3/25). Plan: Charlie's liver is inflammed, and causing him to feel unwell, nauseous and flat. Supportive care is required to reduce this inflammation, including pain relief, antibiotics and anti-emetics/anti-nausea agents. Encourage Charlie to eat and drink is important. Please feed Charlie a bland diet (no raw meat) for the next 2 - 4 weeks. Please monitor for any vomiting, inappetence, lethargy, bruising, collapse, or other signs of concern. A blood sample has been sent to the lab to check Charlie's coagulation parameters. These results will be available early next week and we will contact you with the results. A follow up recheck is recommended in 1 weeks time (or earlier if concerned). Repeat blood test to check liver parameters is recommended in 4 weeks time - at the end of the Hepatoadvanced liver supplement box.
Previous claim history (6)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-03-05 | C09993052 | HEPATOPATHY (LIVER DISORDER) |
| 2026-03-04 | C09987524 | HEPATOPATHY (LIVER DISORDER) |
| 2026-02-12 | C09892680 | Cruciate Disease - Right Leg |
| 2021-04-06 | C3700826 | PYODERMA - SUPERFICIAL |
| 2020-12-14 | C3412324 | INGEST RAT BAIT |
| 2019-09-06 | C2447534 | VOMITING - OTHER - PRESENTING COMPLAINT |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_fluid_therapy | 292.20 | 2026-03-06 | — |
| 20000 | tstarc_hospitalisation | 94.40 | 2026-03-06 | — |
| 30000 | tstarc_hospitalisation | 35.30 | 2026-03-06 | — |
| 40000 | tstarc_procedure_fee | 49.30 | 2026-03-06 | — |
| 50000 | tstarc_antibiotics_-_amoxicillin_and_clavulanic_acid | 101.60 | 2026-03-06 | — |
| 60000 | tstarc_opioids_-_buprenorphine | 45.20 | 2026-03-06 | — |
| 70000 | tstarc_opioids_-_buprenorphine | 45.20 | 2026-03-06 | — |
| 80000 | tstarc_reflux_medication | 63.70 | 2026-03-06 | — |
| 90000 | tstarc_anti-nausea_medication | 41.50 | 2026-03-06 | — |
| 100000 | tstarc_anti-nausea_medication | 88.50 | 2026-03-06 | — |
| 110000 | tstarc_anti-nausea_medication | 100.80 | 2026-03-06 | — |
| 120000 | tstarc_anaesthesia_-_inhalation_anaesthetic | 149.70 | 2026-03-06 | — |
| 130000 | tstarc_diagnostic_test_-_coagulation | 234.90 | 2026-03-06 | — |
| 140000 | tstarc_procedure_fee_-_ultrasound | 486.00 | 2026-03-06 | — |
UPM+
- DG02244HEPATOPATHY (LIVER DISORDER)DSTP_liver_disorder
Variant (sleepy_king)
HEPATOPATHY (LIVER DISORDER)
DSTP_liver_disorder
Conf: 0.780
Threshold: 0.26
Above: ✓
Correct?